Drug – bio-affecting and body treating compositions – Topical body preparation containing solid synthetic organic... – Ophthalmic preparation
Patent
1991-04-22
1993-10-05
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Topical body preparation containing solid synthetic organic...
Ophthalmic preparation
424 7805, 424 7802, 424441, 424449, 424456, 424 45, 514826, 514914, 514887, A61K 31785, A61K 3700, A61K 906, A61K 912
Patent
active
052502937
ABSTRACT:
A method is provided for treating a hypersensitivity disease comprising administering to a human afflicted with such a disease an amount of an anionic polymer effective to counteract the symptoms of a disease selected from the group consisting of bronchial asthma, eosinophil-associated nasal inflammation and vernal conjunctivitis, by counteract
REFERENCES:
patent: 3074852 (1963-01-01), Mayron
patent: 3202557 (1965-08-01), Kaufman
patent: 3330729 (1967-07-01), Johnson
patent: 3608063 (1971-09-01), Banker
patent: 4021387 (1977-05-01), Goetzl et al.
patent: 4226848 (1980-10-01), Nagai et al.
patent: 4322402 (1982-03-01), Ishikawa et al.
patent: 4795436 (1989-01-01), Robinson
patent: 4816449 (1989-03-01), Hahn
patent: 5036056 (1991-07-01), Kludas
P. F. Weller et al., Am. J. Pathol., 100, 793 (1980).
E. J. Goetzl et al., Arch. Pathol., 99, 1 (1975).
R. H. Gundel et al., J. Clin. Invest., 87, 1470 (1991).
R. L. Barker et al., J. Clin. Invest., 88, 798 (1991).
G. J. Gleich et al., J. Allergy Clin. Immunol., 81 776 (1988).
Anionic Polymeric Drugs, L. G. Donaruma et al., eds., Wiley-Interscience, N.Y. (1980) (Chapters 5 and 8).
R. L. Barker et al., FASEB J., 4, A1699, Abstr. 26 (Apr. 26, 1990).
R. M. Ottenbrite, in Anionic Polymeric Drugs, pp. 1-47, L. G. Donamura et al., eds., Wiley Interscience (1980).
A. G. Ellis et al., J. Med. Sci. 136: 407-429 (1908).
B. R. Horn et al, N. Engl. J. Med. 292: 1152-1155 (1975).
G. J. Gleich, J. Exp. Med. 137: 1459-1471 (1973).
T. L. Wasmoen et al., J. Biol Chem. 263: 12559-12563 (1988).
G. J. Gleich, Adv. Immunol. 39: 177-253 (1986).
E. Frigas et al., Lab. Invest. 42: 35-43 (1980).
G. J. Gleich, J. Immunol. 123: 2925-2927 (1979).
M. S. Dunnill, J. Clin. Path. 13: 27-33 (1960).
E. Frigas, Mayo Clinic. Proc. 56: 345-353 (1981).
W. Filley et al., Lancet 2: 11-16 (1982).
S. Motojima et al., Am. Rev. Respir. Dis. 139: 801-805 (1989).
A. T. Hastie et al., Am. Rev. Resp. Dis. 135: [845]848-853 (1987).
N. J. Gross et al., in Allergy, Principles and Practice, (3rd ed.), vol. I, pp. 792-808 (see at p. 790), E. Middleton, Jr. et al., eds. (1988).
A. J. Wardlaw et al., Am. Rev. Resp. Dis. 137: 62-69 (1988).
R. H. Gundel et al., J. Appl. Physiol. 68: 779-786 (1990).
G. H. Ayars et al., in Am. Rev. Resp. Dis. 140: 125-131 (1989).
R. Bascom et al.,, in J. Allergy Clin. Immunol. 84: 338-346 (1989).
T. J. Udell et al., in Am. J. Ophthamol. 92: 824-828 (1981).
S. D. Trocme et al., in Am. J. Ophthamol. 108: 57-63 (1989).
Anionic Polymeric Drugs, L. G. Donaruma et al., eds., Wiley-Interscience (1980). A copy of the Table of Contents of this reference book is enclosed.
C. D. Wegner et al., Respir. Physiol 55: 47 (1984).
E. M. Hodnett et al., J. Med. Chem. 21: 652-657 (1978).
D. S. Breslow, in Am. Chem. Soc. Symposium Series 195: 1-9 (1982).
E. Frigas et al., J. Allergy Clin. Immunol. 77: 527-537 (1986).
G. J. Gleich, Hospital Practice, Mar. 15, 1988: 137-160 (1988).
N. R. Slifman et al., in Allergy Principles and Practice (3rd ed.), vol. I, pp. 179-205, E. Middleton, Jr., et al., eds. (1988).
G. J. Gleich, J. Allergy and Clin. Immunol. 85: 422-436 (1990).
P. L. DeAngelis et al., Biochim. et Biophys. Acta 1037: 100-105 (1990).
Page Thurman K.
Webman Edward J.
LandOfFree
Method for the treatment of hypersensitivity diseases by adminis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the treatment of hypersensitivity diseases by adminis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of hypersensitivity diseases by adminis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1002184